Pfizer refuses to share the patent for its corona vaccine. The American pharmaceutical company thus retains the exclusive right to its production. Critics think this is a bad thing, because Pfizer alone cannot meet the global demand for a vaccine in the slightest.
–
Earlier this month, Pfizer and German biotech company BioNTech announced they could provide a corona vaccine that is as much as 95 percent effective. That is much better than expected. But that the pharmaceutical …
– .
Related posts:
Tesla recalls hundreds of thousands of electric cars from China
Citadele Bank introduces a new contactless payment method
Former US Treasury Secretary: Market Watchers Might Again Misjudge the Economic Situation | Anue Ju...
Hyper Panda Saudi Arabia Offers: Prices starting from 5 Saudi riyals! Don't Miss Out!
